A 32-year-old multiparous woman from Mumbai is diagnosed with gestational diabetes at 26 weeks gestation. She has been on medical nutrition therapy for 2 weeks with home glucose monitoring. Her fasting glucose readings are consistently 110–125 mg/dL and 2-hour postprandial readings are 155–175 mg/dL, both above target. She is overweight (BMI 28 kg/m²) and has no contraindications to insulin or metformin. What is the most appropriate next step?

Question

Accepted Answer

B. Start insulin therapy (NPH or long-acting analog) with dose titration based on glucose readings. ## Pharmacotherapy Initiation in GDM: Insulin as First-Line

**Key Point:** After 2 weeks of MNT failure to achieve glycemic targets, insulin therapy is indicated and is the preferred first-line pharmacological agent in pregnancy.

### Glycemic Targets in GDM

| Measurement | Target (mg/dL) |
|---|---|
| Fasting | <95 |
| 1-hour postprandial | <140 |
| 2-hour postprandial | <120 |

**Clinical Pearl:** This patient's readings (fasting 110–125, postprandial 155–175) exceed all targets, indicating MNT failure. Pharmacotherapy is now indicated.

### Insulin vs. Metformin in Pregnancy

| Feature | Insulin | Metformin |
|---|---|---|
| **Placental transfer** | Minimal (large molecule) | Crosses placenta |
| **Fetal safety** | Excellent; no teratogenicity | Generally safe; less evidence |
| **Maternal hypoglycemia risk** | Yes; requires patient education | Minimal |
| **First-line in pregnancy** | ✓ YES | Second-line; if insulin declined |
| **Efficacy** | Rapid; dose-titrable | Moderate; slower onset |
| **GI side effects** | None | Nausea, diarrhea (10–30%) |

**High-Yield:** Insulin is the gold standard in pregnancy because it does not cross the placenta and has decades of safety data. Metformin is a reasonable alternative if the patient refuses insulin, but it is NOT first-line.

### Insulin Regimens in GDM

1. **Basal-bolus (preferred)**
   - Long-acting basal: NPH at bedtime or long-acting analog (glargine, detemir)
   - Rapid-acting bolus: Aspart or lispro before meals
   - Allows flexible meal timing and better glycemic control

2. **Premixed insulin**
   - Less flexible; fixed carbohydrate intake required

**Mnemonic:** **INSULIN FIRST** in GDM pregnancy — **I**nsulin is safest, **N**o placental transfer, **S**ulin has decades of safety, **U**nlike metformin which crosses, **L**ong-acting basal + rapid bolus, **I**mmediately effective, **N**eed dose titration, **F**etal safety paramount, **I**ncrease doses as pregnancy progresses, **R**apid-acting for meals, **S**tart low, titrate up, **T**arget fasting <95, postprandial <120.

### Dose Initiation

- **Starting dose:** 0.7–1.0 IU/kg/day divided as 50% basal, 50% bolus
- **Titration:** Increase by 2–4 IU every 3 days based on glucose readings
- **Insulin requirement increases** as pregnancy advances (up to 2–3× by third trimester)

**Warning:** Do NOT continue MNT alone beyond 2 weeks if targets are unmet; this delays fetal benefit and increases maternal/fetal complications.

Answer

A. Continue MNT for another 2 weeks; reassess and add insulin only if targets remain unmet

Answer

C. Initiate metformin 1000 mg twice daily as it is safer than insulin in pregnancy

Answer

D. Perform repeat OGTT to confirm GDM diagnosis before initiating pharmacotherapy

Explanation

Pharmacotherapy Initiation in GDM: Insulin as First-Line

Glycemic Targets in GDM

Insulin vs. Metformin in Pregnancy

Insulin Regimens in GDM

Dose Initiation

Practice similar questions

Join our NEET PG community

Feature	Insulin	Metformin
Placental transfer	Minimal (large molecule)	Crosses placenta
Fetal safety	Excellent; no teratogenicity	Generally safe; less evidence
Maternal hypoglycemia risk	Yes; requires patient education	Minimal
First-line in pregnancy	✓ YES	Second-line; if insulin declined
Efficacy	Rapid; dose-titrable	Moderate; slower onset
GI side effects	None	Nausea, diarrhea (10–30%)